The medical landscape is experiencing a change with the introduction of GLP-1 delivery devices. These exciting formulations offer a possible approach to providing glucagon-like peptide-1 drugs for individuals battling hyperglycemia. Instead of daily shots , a convenient patch affixed to the skin could administer a steady dose of the substance, pote